Search for: "Hall v. Pfizer Inc" Results 1 - 20 of 31
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jul 2012, 12:40 pm by Bexis
Pfizer, Inc., 990 A.2d 17, 21 n.1 (Pa.Super. 2010) (rejecting fraud claim concerning promotion “for off-label uses for which the effectiveness had not been scientifically demonstrated”). [read post]
31 Dec 2009, 11:46 am by Beck, et al.
Pfizer Hospital Products Group, Inc., 872 S.W.2d 908, 911-12 (Tenn. [read post]
18 Jul 2014, 11:55 am
Pfizer, Inc., 716 F.3d 1087, 1092-93 (8th Cir. 2013). [read post]
3 Mar 2016, 5:19 am
Pfizer, Inc., 153 S.W.3d 758, 766 (Ky. 2004) (DTC exception “recognized only by New Jersey”); Mendez Montes De Oca v. [read post]
18 Sep 2013, 7:28 am
 The IPKat has stumbled across a decision earlier this year from the Federal Court, Canada, in Pfizer Canada Inc. v Pharmascience Inc. 2013 FC 120, dating back to 4 February. [read post]
2 Jun 2011, 12:46 pm by Bexis
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
27 May 2010, 3:40 pm by Bexis
Wyeth-Ayerst Laboratories, Inc., 1998 WL 81296 (9th Cir. 1998) (“anecdotal reports . . . do not attempt to isolate causes and are not intended to reach conclusions as to causation”) (in table at 139 F.3d 905).Hall v. [read post]